Mixed Lineage Kinases (MLKs): a Role in Dendritic Cells, Inflammation and Immunity?

Overview

Journal Int J Exp Pathol

Publisher Wiley

Specialty Pathology

Date 2007 Apr 6

PMID 17408454

Citations 22

Authors

Matthew E Handley

Jane Rasaiyaah

Benjamin M Chain

David R Katz

Affiliations

Soon will be listed here.

Abstract

This review summarizes current knowledge about the mixed lineage kinases (MLKs) and explores their potential role in inflammation and immunity. MLKs were identified initially as signalling molecules in the nervous system. They were also shown to play a role in the cell cycle. Further studies documented three groups of MLKs, and showed that they may be activated via the c-Jun NH(2) terminal kinase (JNK) pathway, and by Rho GTPases. The biochemistry of the MLKs has been investigated in considerable detail. Homodimerization and heterodimerization can occur, and both autophosphorylation and autoinhibition are seen. The interaction between MLKs and JNK interacting protein (JIP) scaffolds, and the resultant effects on mitogen activated protein kinases, have been identified. Clearly, there is some redundancy within the MLK pathway(s), since mice which lack the MLK3 molecule are not abnormal. However, using a combination of biochemical analysis and pharmacological inhibitors, several recent studies in vitro have suggested that MLKs are not only expressed in cells of the immune system (as well as in the nervous system), but also may be implicated selectively in the signalling pathway that follows on toll-like receptor ligation in innate sentinel cells, such as the dendritic cell.

Citing Articles

Disrupting PIAS3-mediated SUMOylation of MLK3 ameliorates poststroke neuronal damage and deficits in cognitive and sensorimotor behaviors.

Jiang Y, Hu L, Wang B, Zhang B, Shao M, Meng L Cell Mol Life Sci. 2024; 81(1):119.

PMID: 38456949 PMC: 10924033. DOI: 10.1007/s00018-024-05166-7.

MLK3 silence suppressed osteogenic differentiation and delayed bone formation via influencing the bone metabolism and disturbing MAPK signaling.

Yang X, Mai Y, Wei L, Peng L, Pang F, Wang L J Orthop Translat. 2022; 38:98-105.

PMID: 36381243 PMC: 9619354. DOI: 10.1016/j.jot.2022.07.003.

MLK3 Regulates Inflammatory Response via Activation of AP-1 Pathway in HEK293 and RAW264.7 Cells.

Ha A, Cho J, Kim D Int J Mol Sci. 2022; 23(18).

PMID: 36142785 PMC: 9501218. DOI: 10.3390/ijms231810874.

Advances in Immunosuppressive Agents Based on Signal Pathway.

Xu Z, Chu M Front Pharmacol. 2022; 13:917162.

PMID: 35694243 PMC: 9178660. DOI: 10.3389/fphar.2022.917162.

Cdc42/Rac Interactive Binding Containing Effector Proteins in Unicellular Protozoans With Reference to Human Host: Locks of the Rho Signaling.

Umarao P, Rath P, Gourinath S Front Genet. 2022; 13:781885.

PMID: 35186026 PMC: 8847673. DOI: 10.3389/fgene.2022.781885.

References

Kiefer F, Tibbles L, Anafi M, Janssen A, Zanke B, Lassam N . HPK1, a hematopoietic protein kinase activating the SAPK/JNK pathway. EMBO J. 1996; 15(24):7013-25. PMC: 452527. View

Tibbles L, Ing Y, Kiefer F, Chan J, Iscove N, Woodgett J . MLK-3 activates the SAPK/JNK and p38/RK pathways via SEK1 and MKK3/6. EMBO J. 1996; 15(24):7026-35. PMC: 452528. View

Tapon N, Hall A . Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton. Curr Opin Cell Biol. 1997; 9(1):86-92. DOI: 10.1016/s0955-0674(97)80156-1. View

Perona R, Montaner S, Saniger L, Sanchez-Perez I, Bravo R, Lacal J . Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins. Genes Dev. 1997; 11(4):463-75. DOI: 10.1101/gad.11.4.463. View

Rasmussen R, Ji H, Eddes J, Moritz R, Reid G, Simpson R . Two-dimensional electrophoretic analysis of human breast carcinoma proteins: mapping of proteins that bind to the SH3 domain of mixed lineage kinase MLK2. Electrophoresis. 1997; 18(3-4):588-98. DOI: 10.1002/elps.1150180342. View

Hirai S, Katoh M, Terada M, Kyriakis J, Zon L, Rana A . MST/MLK2, a member of the mixed lineage kinase family, directly phosphorylates and activates SEK1, an activator of c-Jun N-terminal kinase/stress-activated protein kinase. J Biol Chem. 1997; 272(24):15167-73. DOI: 10.1074/jbc.272.24.15167. View

BRAGA V, Machesky L, Hall A, Hotchin N . The small GTPases Rho and Rac are required for the establishment of cadherin-dependent cell-cell contacts. J Cell Biol. 1997; 137(6):1421-31. PMC: 2132529. DOI: 10.1083/jcb.137.6.1421. View

Medzhitov R, Preston-Hurlburt P, Janeway Jr C . A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 1997; 388(6640):394-7. DOI: 10.1038/41131. View

Sakuma H, Ikeda A, Oka S, Kozutsumi Y, Zanetta J, Kawasaki T . Molecular cloning and functional expression of a cDNA encoding a new member of mixed lineage protein kinase from human brain. J Biol Chem. 1997; 272(45):28622-9. DOI: 10.1074/jbc.272.45.28622. View

10.

Maroney A, Glicksman M, Basma A, Walton K, KNIGHT Jr E, Murphy C . Motoneuron apoptosis is blocked by CEP-1347 (KT 7515), a novel inhibitor of the JNK signaling pathway. J Neurosci. 1998; 18(1):104-11. PMC: 6793399. View

11.

Nagata K, Puls A, Futter C, Aspenstrom P, Schaefer E, Nakata T . The MAP kinase kinase kinase MLK2 co-localizes with activated JNK along microtubules and associates with kinesin superfamily motor KIF3. EMBO J. 1998; 17(1):149-58. PMC: 1170366. DOI: 10.1093/emboj/17.1.149. View

12.

Tanaka S, Hanafusa H . Guanine-nucleotide exchange protein C3G activates JNK1 by a ras-independent mechanism. JNK1 activation inhibited by kinase negative forms of MLK3 and DLK mixed lineage kinases. J Biol Chem. 1998; 273(3):1281-4. DOI: 10.1074/jbc.273.3.1281. View

13.

Angeles T, Yang S, Steffler C, Dionne C . Kinetics of trkA tyrosine kinase activity and inhibition by K-252a. Arch Biochem Biophys. 1998; 349(2):267-74. DOI: 10.1006/abbi.1997.0490. View

14.

Merritt S, Mata M, Nihalani D, Zhu C, Hu X, Holzman L . The mixed lineage kinase DLK utilizes MKK7 and not MKK4 as substrate. J Biol Chem. 1999; 274(15):10195-202. DOI: 10.1074/jbc.274.15.10195. View

15.

Maroney A, Finn J, Bozyczko-Coyne D, OKane T, Neff N, Tolkovsky A . CEP-1347 (KT7515), an inhibitor of JNK activation, rescues sympathetic neurons and neuronally differentiated PC12 cells from death evoked by three distinct insults. J Neurochem. 1999; 73(5):1901-12. View

16.

Kelkar N, Gupta S, Dickens M, Davis R . Interaction of a mitogen-activated protein kinase signaling module with the neuronal protein JIP3. Mol Cell Biol. 2000; 20(3):1030-43. PMC: 85220. DOI: 10.1128/MCB.20.3.1030-1043.2000. View

17.

Nihalani D, Merritt S, Holzman L . Identification of structural and functional domains in mixed lineage kinase dual leucine zipper-bearing kinase required for complex formation and stress-activated protein kinase activation. J Biol Chem. 2000; 275(10):7273-9. DOI: 10.1074/jbc.275.10.7273. View

18.

Hehner S, Hofmann T, Ushmorov A, Dienz O, Lassam N, Scheidereit C . Mixed-lineage kinase 3 delivers CD3/CD28-derived signals into the IkappaB kinase complex. Mol Cell Biol. 2000; 20(7):2556-68. PMC: 85472. DOI: 10.1128/MCB.20.7.2556-2568.2000. View

19.

Bock B, Vacratsis P, Qamirani E, Gallo K . Cdc42-induced activation of the mixed-lineage kinase SPRK in vivo. Requirement of the Cdc42/Rac interactive binding motif and changes in phosphorylation. J Biol Chem. 2000; 275(19):14231-41. DOI: 10.1074/jbc.275.19.14231. View

20.

Levchenko A, Bruck J, Sternberg P . Scaffold proteins may biphasically affect the levels of mitogen-activated protein kinase signaling and reduce its threshold properties. Proc Natl Acad Sci U S A. 2000; 97(11):5818-23. PMC: 18517. DOI: 10.1073/pnas.97.11.5818. View